Title: Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, source says
Article Snip: "...expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source told Reuters on Tuesday.
Patients in the U.S. currently pay the most for prescription medicines, often nearly three times more than in other developed nations, and President Donald Trump has been pressuring drugmakers to lower their prices to what patients pay elsewhere. ..."
No comments:
Post a Comment